Clin2
NCT06461208Possibly a fitRecruiting

Fecal transplant for people with cirrhosis

Liver Cirrhosis

Part of Brain & nervous system, Digestive system, Hormones & metabolism, Infections clinical trials.

This trial tests whether transplanting healthy gut bacteria (from donor stool) can improve outcomes in people with cirrhosis. If you have mild to moderate cirrhosis, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have cirrhosis caused by alcohol, fatty liver disease, or a mix of both
  • Your liver disease is mild to moderate (MELD score between 8 and 16)
  • If you have alcohol-related cirrhosis, you drink no more than about 2.5 units of alcohol per day
  • You do not have severe food allergies, are not pregnant or breastfeeding, and have not had a liver transplant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04932577Recruiting· Phase 2/Phase 3
Fecal transplant to treat complications of liver cirrhosis

This trial studies whether transferring healthy gut bacteria (from a donor sample) can improve outcomes for people with liver cirrhosis who have worsening complications. It may help by changing the gut microbiome, which can influence inflammation and liver health.

Aarhus
NCT06496191Recruiting
Fecal transplant for alcohol use in cirrhotics

This trial tests whether a fecal microbiota transplant (FMT) can help people with alcohol-related cirrhosis who are still drinking. It aims to see if FMT can reduce alcohol cravings and improve liver health.

New Delhi, National Capital Territory of Delhi
NCT06286709Recruiting· Phase 2
Fecal transplant for PSC and colitis

This trial tests whether a fecal (stool) transplant from a healthy donor can help people with both PSC and inflammatory bowel disease. It aims to see if the treatment can improve liver health and reduce inflammation. You must have early to moderate liver scarring and be on stable medications.

Birmingham
NCT04188743Recruiting· Phase 2/Phase 3
Stool transplant to clear antibiotic-resistant gut germs

This trial tests whether a stool (fecal) transplant from a screened donor can help remove antibiotic-resistant gut bacteria (MDRO) that keep coming back in your stool tests. It aims to reduce colonization that makes follow-up and treatment harder.

Ghent, Oost-Vlaanderen
NCT06533852Recruiting· Phase 3
Fecal transplant trial for liver cirrhosis complications

This study tests whether stool from healthy donors can help people with advanced liver disease (cirrhosis) who have had complications like fluid buildup. You would receive the transplant through a colonoscopy or enema.

Barcelona
NCT05006430Recruiting· Phase 1/Phase 2
Fecal transplant study for severe alcoholic hepatitis safety

This trial tests whether fecal microbiota transplantation (a controlled transfer of stool bacteria) is safe in people with severe alcoholic hepatitis. It aims to see if the treatment is tolerable and what risks may come with it, in addition to watching how liver illness changes.

Houston, Texas

Hear when a new Liver Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.